Veterinary Medicines

Novamune Concentrate and Solvent for Suspension for Injection for Chickens

Authorised
  • Infectious bursal disease virus, Live
Download as PDF

Product identification

Medicine name:
Novamune Concentrate and Solvent for Suspension for Injection for Chickens
Novamune Concentraat voor suspensie voor injectie
Novamune Suspension à diluer pour suspension injectable
Novamune Konzentrat zur Herstellung einer Injectionssuspension
Active substance:
  • Infectious bursal disease virus, Live
Target species:
  • Chicken
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, Live
    4.20
    log 10 50% infective dose in chicken
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • bag containing 1600 ml
  • bag containing 1200 ml
  • bag containing 1000 ml
  • bag containing 800 ml
  • bag containing 400 ml
  • bag containing 200 ml
  • ampoule of 5 ml containing 2000 doses
  • ampoule of 5 ml containing 1000 doses
  • ampoule of 5 ml containing 500 doses
  • ampoule of 2 ml containing 1000 doses
  • ampoule of 2 ml containing 500 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V534062
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0365/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download

eu-PUAR-novamune-concentrate-and-solvent-for-suspension-for-injection-for-chickens-en.pdf

English (PDF)
Published on: 12/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."